Leading U.S. Government-Accredited Lab Confirms Path-Away(R) Natural Active Ingredient Can Kill Actual COVID-19 Virus Within ...
20 October 2020 - 1:00PM
JCN Newswire (English)
Sydney, Kuala Lumpur, Bluffton, SC (USA), Oct 20, 2020 - (ACN
Newswire) - A leading laboratory acceredited with U.S. Government
agencies has released test results which confirm that Path-Away(R)
- a plant-based active ingredient that contains no chemicals or
alcohol - can kill the actual virus that causes COVID-19 within two
minutes, the global distributor of Path-Away(R) announced
today.
Holista Colltech Limited (ASX: HCT, or Holista), the
Malaysian-based global distributor, and Global Infection Control
Consultants, LLC (GICC LLC), the developer of Path-Away(R), said
they believe the tests confirm the active ingredient to be the
world's first totally natural and safe organic disinfectant to meet
the U.S. testing standard.
The independent tests of the Path-Away(R) Anti Pathogenic Aerosol
Solution on SARS-CoV-2, the actual virus that causes COVID-19, were
undertaken by Microbac Laboratories, Inc. (Microbac) in the United
States. With over 50 years' experience, Microbac is accredited
under the U.S. Department of Defence (DoD) and Environmental
Laboratory Accreditation Program (ELAP).
The Microbac tests were conducted using the direct inoculation
method and follow successful tests in an approved laboratory in the
United Kingdom (completed in April 2020) of the efficacy of
Path-Away(R) against the feline coronavirus which is a recognised
surrogate of SARS-CoV-2. Path-Away(R) has also proven to be
effective against a broad spectrum of microbes including the SARS
and the H1N1 viruses.
Listed on the Australia Securities Exchange (ASX), Holista
distributes Path-Away(R) under its own NatShield(TM) and
Protectene(TM) brands. Apart from a hand sanitiser, Holista and
GICC LLC are also co-developing a NatShield(TM) nasal balm that
will include Path-Away(R). This balm is expected to be launched
before the end of 2020.
The latest test results will significanly accelerate efforts to
roll out the M3 System(R), also developed by GICC LLC, which can
disinfect large buildings by dispensing Path-Away(R) through
heating, ventilation and air-conditioning ("HVAC") systems to treat
harmful pathogens, including airborne viruses.
GICC LLC, based in Bluffton, South Carolina, has recently secured a
36-month contract with the U.S. Government to manufacture and
install up to 10 million units of its M3 System(R) in large
buildings. The system measures, monitors and contains airborne
(aerosol) viruses, pathogens and other biological contaminants.
Holista and GICC LLC concurrently announced that they will form a
51:49 joint-venture company in Singapore which will have the rights
to manufacture the M3 System(R) outside the United States. Holista
is exclusive global distributor of the M3 System(R) excluding the
United States, China and the Gulf states.
Apart from global distribution rights of Path-Away(R) for use as a
sanitiser under the NatShield(TM) and Protectene(TM) brands,
Holista also has rights to distribute Path-Away(R) for use in
aerosolised disinfection of buildings using a high-pressure
fogger.
Dr Arthur V Martin, the president of GICC LLC, commented: "To the
best of my knowledge, this is the first time a completely natural,
all-organic compound has been successfully proven to kill the
actual virus causing COVID-19, to 99.9% within two minutes. We are
excited because this will allow us to speed up the formal U.S.
Government process of listing on the Environmental Protection
Agency's (EPA) "N-List". EPA expects the products on "List N" to
kill SARS-CoV-2 within two minutes. This will also allow for a
wider use of this all-natural disinfectant for human use. The
findings by Microbac confirm what we have known about the
effectiveness of Path-Away(R) on other coronaviruses. The results
are also particularly pleasing in light of recent research that
showed that COVID-19 can survive on surfaces far longer than
scientists had originally calculated."
Dr. Roscoe Moore Jr., D.V.M., Ph.D., D.Sc., Former Assistant U.S.
Surgeon and member of the Global Virus Network and its
International COVID-19 Taskforce, said "There is a big need for
natural and human friendly disinfectants that can be used
frequently and safely without long term health side effects and
while being environmentally safe. The recent tests from Microbac
are most welcome as the public is looking for an agent that acts
specifically against COVID-19". Dr Moore also chairs Holista's
Scientific Advisory Board.
Dr Rajen Manicka, Chief Executive Officer of Holista, commented:
"This product will address the significant untapped global market
for all-natural disinfectants that are safe to be used on hands and
faces. The results from Microbac will give our customers a greater
level of confidence that NatShield(TM) and Protectene(TM) can be
effective on skin, surfaces and as an aerosol, against the highly
contagious COVID-19 causing virus. We have fielded enquiries from
large organisations which need to disinfect buildings and
facilities with sizeable human traffic. We are also preparing a
submission to the Australian Therapeutic Goods Administration (TGA)
for approval to label our Natshield(TM) and Protectene(TM) range of
sanitizing and disinfectant products, as well as to have Natshield
approved for aerosol delivery through fogging units and through
buildings' HVAC systems in Australia."
Information of Path-Away(R) and Microbac Test Results
How Path-Away(R) Works
Path-Away(R) attaches itself to the virus and inhibits its ability
to take up amino acids - their basic building block. This forces
the viruses to clump together, in the process killing themselves,
almost instantly. The compound is environmentally safe with very
low toxicity and does not harm humans and pets.
Details of Results of Tests Conducted By Microbac
- Cells containing the SARS-CoV-2 virus were seeded in 24-well
plates and 2.0 mL (millilitres) of Path-Away(R) was added to the
(live frozen samples - thawed out) dried virus inoculum and held
for the contact time of 2 minutes at 21 degrees C with 53% relative
humidity (RH). For the test to be deemed successful, Path-Away(R)
must demonstrate a ≥ 3 Log10 reduction on each test carrier
in the presence or absence of cytotoxicity.
- Path-Away(R) achieved this benchmark in each of the 24 instances
(100% success rate). All controls met the criteria for a valid test
and Microbac's conclusions are based on observed data.
- Log Reduction stands for a 10-fold (one decimal) or 90% reduction
in numbers of live bacteria. A 3-Log Reduction equates to a 99.9%
reduction - greater than 1,000 time reduction in potentially
harmful microorganisms.
- Path-Away(R), killed 99.9% (≥ 3 Log10) of the COVID-19
causing virus on a hard surface after being exposed to
Path-Away(R).
- The full test report and process will be featured on the Holista
website at https://www.holistaco.com/
About Holista Colltech Limited
Holista Colltech Ltd ("Holista") is a natural wellness company with
the following divisions:
- Dietary supplements
- Food Ingredients
- Ovine collagen
- Infection Control Solutions
Holista has a global collaboration with Global Infection Control
Consultants LLC to use Path-Away(R), a plant-based solution that is
proven to kill a broad spectrum of microbes. The all-natural
alcohol-free active ingredient is used in Holista's range of
disinfectant products under the NatShield(TM) brand.
For further information, please contact:
Corporate Matters: investor@holistaco.com
General Enquiries: enquiries@holistaco.com
Global Investor relations and media enquiries:
WeR1 Consultants Pte Ltd
E: holista@wer1.net
T: +65 673 74 844
Source: Holista CollTech Ltd
Copyright 2020 ACN Newswire . All rights reserved. |
Holista Colltech (ASX:HCT)
Historical Stock Chart
From Apr 2024 to May 2024
Holista Colltech (ASX:HCT)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Holista Colltech Limited (Australian Stock Exchange): 0 recent articles
More Holista Colltech Limited News Articles